These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8939206)

  • 41. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective multicenter study of second-trimester nuchal skinfold thickness in unaffected and Down syndrome pregnancies.
    Donnenfeld AE; Carlson DE; Palomaki GE; Librizzi RJ; Weiner S; Platt LD
    Obstet Gynecol; 1994 Nov; 84(5):844-7. PubMed ID: 7936524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: results of a prospective clinical trial.
    Crane JP; Gray DL
    Obstet Gynecol; 1991 Apr; 77(4):533-6. PubMed ID: 1825865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontal lobe shortening in second-trimester fetuses with trisomy 21: usefulness as a US marker.
    Winter TC; Reichman JA; Luna JA; Cheng EY; Doll AM; Komarniski CA; Nghiem HV; Schmiedl UP; Shields LE; Uhrich SB
    Radiology; 1998 Apr; 207(1):215-22. PubMed ID: 9530318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
    Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
    Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The anterior iliac separation: alternative index for pelvic morphometry in fetuses with Down syndrome.
    Kliewer MA; Hertzberg BS; Freed KS; McNally PJ; DeLong DM
    AJR Am J Roentgenol; 2001 Apr; 176(4):1003-7. PubMed ID: 11264098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Choroid plexus cysts: not associated with Down syndrome.
    Bromley B; Lieberman R; Benacerraf BR
    Ultrasound Obstet Gynecol; 1996 Oct; 8(4):232-5. PubMed ID: 8916374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can the risk for Down syndrome be reliably modified by second-trimester ultrasonography?
    Palomaki GE; Haddow JE
    Am J Obstet Gynecol; 1995 Nov; 173(5):1639-40. PubMed ID: 7503224
    [No Abstract]   [Full Text] [Related]  

  • 49. Elevated hCG as an isolated finding during the second trimester biochemical screen: genetic, ultrasonic, and perinatal significance.
    Fejgin MD; Kedar I; Amiel A; Ben-Tovim T; Chen R; Petel Y; Tepper R
    Prenat Diagn; 1997 Nov; 17(11):1027-31. PubMed ID: 9399350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fetal plexus cysts. An indication for prenatal karyotyping].
    Werner-von der Burg W; Hatzmann W; Kuchenbecker K
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):674-80. PubMed ID: 1452002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Trisomy 21. 209 cases from the French College of Fetal Ultrasonography. Pertinence of ultrasonographic signs].
    Le Duff D
    Contracept Fertil Sex; 1997 Dec; 25(12):VII-XIV. PubMed ID: 9497609
    [No Abstract]   [Full Text] [Related]  

  • 52. Down's syndrome screening with nuchal translucency.
    Hackshaw AK; Wald NJ; Haddow JE
    Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459
    [No Abstract]   [Full Text] [Related]  

  • 53. [Detection of chromosomal abnormalities using cordocentesis].
    Zolotukhina TV; Kuznetsov MI; Kostiuk EV; Shilova NV; Solonichenko VG
    Genetika; 1991 Aug; 27(8):1481-5. PubMed ID: 1722186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal transcerebellar diameter in Down syndrome.
    Rotmensch S; Goldstein I; Liberati M; Shalev J; Ben-Rafael Z; Copel JA
    Obstet Gynecol; 1997 Apr; 89(4):534-7. PubMed ID: 9083308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetic sonogram in second trimester down syndrome screening.
    Egan JF
    Clin Obstet Gynecol; 2003 Dec; 46(4):897-908. PubMed ID: 14595233
    [No Abstract]   [Full Text] [Related]  

  • 57. Macroglossia: prenatal ultrasonographic diagnosis and proposed management.
    Weissman A; Mashiach S; Achiron R
    Prenat Diagn; 1995 Jan; 15(1):66-9. PubMed ID: 7740001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What does the patient really have to know about the presence of minor markers on the second-trimester sonogram?
    Benacerraf BR
    J Ultrasound Med; 2010 Apr; 29(4):509-12. PubMed ID: 20375369
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: Trisomy 21: 91% detection rate using second-trimester ultrasound markers.
    Hutchon DJ
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):83-4. PubMed ID: 11489234
    [No Abstract]   [Full Text] [Related]  

  • 60. Separation of the great toe in fetuses with Down syndrome.
    Wilkins I
    J Ultrasound Med; 1994 Mar; 13(3):229-31. PubMed ID: 7932983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.